Literature DB >> 14243441

COMPARISON OF TUMOUR ANTIGENS IN AKR AND GROSS VIRUS (PASSAGE A)-INDUCED LEUKAEMIAS.

B WAHREN.   

Abstract

Entities:  

Keywords:  ANTIGENS; BLOOD; EXPERIMENTAL LAB STUDY; IMMUNIZATION; LEUKEMIA, EXPERIMENTAL; MICE; NEOPLASM IMMUNOLOGY; NEOPLASM TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY

Mesh：

Substances：

Year:  1965        PMID： 14243441     DOI： 10.1038/205409a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  The antibody response of mice to murine leukemia virus in spontaneous infection: absence of classical immunologic tolerance (AKR mice-complement-fixing antibodies-lymphocytic choriomeningitis virus-immunofluorescence-glomerular deposits of antigen-antibody complexes).

Authors:  M B Oldstone; T Aoki; F J Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

2.  [Immunological properties of Graffi virus-induced leukemias of the AKR mouse strain].

Authors:  G Pasternak; F Fey; L Pasternak; B Hölzer
Journal:  Z Krebsforsch       Date:  1967

3.  Cytotoxicity in vitro of preleukaemic lymphoid cells on syngeneic monolayers of embryo or thymus cells.

Authors:  B Wahren; D Metcalf
Journal:  Clin Exp Immunol       Date:  1970-09       Impact factor: 4.330

4.  The G-IX system. A cell surface allo-antigen associated with murine leukemia virus; implications regarding chromosomal integration of the viral genome.

Authors:  E Stockert; L J Old; E A Boyse
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

5.  Wild-type gross leukemia virus: classification of soluble antigens (GSA).

Authors:  T Aoki; R B Herberman; P A Johnson; M Liu; M M Sturm
Journal:  J Virol       Date:  1972-12       Impact factor: 5.103

6.  Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses.

Authors:  G Geering; L J Old; E A Boyse
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.